Literature DB >> 10413036

Measurement of changes in opioid receptor binding in vivo during trigeminal neuralgic pain using [11C] diprenorphine and positron emission tomography.

A K Jones1, N D Kitchen, H Watabe, V J Cunningham, T Jones, S K Luthra, D G Thomas.   

Abstract

The binding of [11C]diprenorphine to mu, kappa, and delta subsites in cortical and subcortical structures was measured by positron emission tomography in vivo in six patients before and after surgical relief of trigeminal neuralgia pain. The volume of distribution of [11C]diprenorphine binding was significantly increased after thermocoagulation of the relevant trigeminal division in the following areas: prefrontal, insular, perigenual, mid-cingulate and inferior parietal cortices, basal ganglia, and thalamus bilaterally. In addition to the pain relief associated with the surgical procedure, there also was an improvement in anxiety and depression scores. In the context of other studies, these changes in binding most likely resulted from the change in the pain state. The results suggest an increased occupancy by endogenous opioid peptides during trigeminal pain but cannot exclude coexistent down-regulation of binding sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413036     DOI: 10.1097/00004647-199907000-00011

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  19 in total

Review 1.  Functional imaging of pain perception.

Authors:  Anthony K P Jones; Bhavna Kulkarni; Stuart W G Derbyshire
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

2.  Alterations in endogenous opioid functional measures in chronic back pain.

Authors:  Ilkka K Martikainen; Marta Peciña; Tiffany M Love; Emily B Nuechterlein; Chelsea M Cummiford; Carmen R Green; Richard E Harris; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 3.  Predictive mechanisms linking brain opioids to chronic pain vulnerability and resilience.

Authors:  Anthony Kenneth Peter Jones; Christopher Andrew Brown
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

Review 4.  Migraine and the Mu-opioidergic system-Can we directly modulate it? Evidence from neuroimaging studies.

Authors:  Alexandre F DaSilva; Thiago D Nascimento; Marcos F DosSantos; Jon-Kar Zubieta
Journal:  Curr Pain Headache Rep       Date:  2014-07

Review 5.  [Neuropathic pain and neuroplasticity in functional imaging studies].

Authors:  C Maihöfner; F T Nickel; F Seifert
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

6.  Opioids and social bonding: Effect of naltrexone on feelings of social connection and ventral striatum activity to close others.

Authors:  Tristen K Inagaki; Laura I Hazlett; Carmen Andreescu
Journal:  J Exp Psychol Gen       Date:  2019-08-15

7.  A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia.

Authors:  Darin D Dougherty; Jian Kong; Megan Webb; Ali A Bonab; Alan J Fischman; Randy L Gollub
Journal:  Behav Brain Res       Date:  2008-05-02       Impact factor: 3.332

Review 8.  Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges.

Authors:  Stephen Bruehl; A Vania Apkarian; Jane C Ballantyne; Ann Berger; David Borsook; Wen G Chen; John T Farrar; Jennifer A Haythornthwaite; Susan D Horn; Michael J Iadarola; Charles E Inturrisi; Lixing Lao; Sean Mackey; Jianren Mao; Andrea Sawczuk; George R Uhl; James Witter; Clifford J Woolf; Jon-Kar Zubieta; Yu Lin
Journal:  J Pain       Date:  2013-02       Impact factor: 5.820

9.  mu-opioid receptor-mediated antinociceptive responses differ in men and women.

Authors:  Jon-Kar Zubieta; Yolanda R Smith; Joshua A Bueller; Yanjun Xu; Michael R Kilbourn; Douglas M Jewett; Charles R Meyer; Robert A Koeppe; Christian S Stohler
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

Review 10.  [Positron emission tomography in pain research. From the structure to the activity of the opiate receptor system].

Authors:  T Sprenger; G Henriksen; M Valet; S Platzer; A Berthele; T R Tölle
Journal:  Schmerz       Date:  2007-11       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.